Metabolic syndrome in older adults: a poblational study

Metabolic syndrome (MS) is a set of metabolic alterations considered a risk factor for developing cardiovascular disease and diabetes. In recent years, due to harmful changes in lifestyle, the increase in the prevalence of SM worldwide is alarming. In Argentina, epidemiological studies on SM re...

Descripción completa

Detalles Bibliográficos
Autores principales: Díaz-Gerevini, GT, Priotto, S, Barotto, NN, Astorquiza, P, Barboza, MC, López, PM, Farías, S, Repossi, G
Formato: Artículo revista
Lenguaje:Español
Publicado: Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología 2023
Materias:
Metabolic Syndrome
older adults
Epidemiology
Síndrome metabólico
Adultos Mayores
epidemiologia
Acceso en línea:https://revistas.unc.edu.ar/index.php/med/article/view/42714
Aporte de:
Revista de la Facultad de Ciencias Médicas de Córdoba de Universidad Nacional de Córdoba
id I10-R327-article-42714
record_format ojs
institution Universidad Nacional de Córdoba
institution_str I-10
repository_str R-327
container_title_str Revista de la Facultad de Ciencias Médicas de Córdoba
language Español
format Artículo revista
topic Metabolic Syndrome
older adults
Epidemiology
Síndrome metabólico
Adultos Mayores
epidemiologia
spellingShingle Metabolic Syndrome
older adults
Epidemiology
Síndrome metabólico
Adultos Mayores
epidemiologia
Díaz-Gerevini, GT
Priotto, S
Barotto, NN
Astorquiza, P
Barboza, MC
López, PM
Farías, S
Repossi, G
Metabolic syndrome in older adults: a poblational study
topic_facet Metabolic Syndrome
older adults
Epidemiology
Síndrome metabólico
Adultos Mayores
epidemiologia
author Díaz-Gerevini, GT
Priotto, S
Barotto, NN
Astorquiza, P
Barboza, MC
López, PM
Farías, S
Repossi, G
author_facet Díaz-Gerevini, GT
Priotto, S
Barotto, NN
Astorquiza, P
Barboza, MC
López, PM
Farías, S
Repossi, G
author_sort Díaz-Gerevini, GT
title Metabolic syndrome in older adults: a poblational study
title_short Metabolic syndrome in older adults: a poblational study
title_full Metabolic syndrome in older adults: a poblational study
title_fullStr Metabolic syndrome in older adults: a poblational study
title_full_unstemmed Metabolic syndrome in older adults: a poblational study
title_sort metabolic syndrome in older adults: a poblational study
description Metabolic syndrome (MS) is a set of metabolic alterations considered a risk factor for developing cardiovascular disease and diabetes. In recent years, due to harmful changes in lifestyle, the increase in the prevalence of SM worldwide is alarming. In Argentina, epidemiological studies on SM report a prevalence of 25%. One of the groups at highest risk for this syndrome are older adults. Objectives: Determine the prevalence of MS and its diagnostic components. To analyze whether MS is associated with an increase in mortality. A retrospective observational study was carried out (period 2018-2022) of all medical records (n=1020) of older adults (≥65 years), patients at the San Ricardo Pampuri Medical Center, Villa Carlos Paz, Córdoba. Diagnostic criteria for MS: present at least 3 of these 5 components: 1-BMI≥30; 2-Triglycerides ≥ 150 mg/dL; 3-HDL cholesterol ≤40 mg/dL in men or ≤50 mg/dL in women and/or total cholesterol ≥ 200 mg/dL; 4-Elevated blood pressure ≥140/90 mmHg; 5- Fasting glucose ≥100 mg/dL. These variables were analyzed and the prevalence of MS was determined. Mortality and its causes were studied and the risk for patients with MS was calculated. Statistical analysis was performed with Infostat (p≤0.05), ANOVA (Tukey post hoc) tests were used for continuous variables and Chi square for discrete variables. In this work, the rules of confidentiality and anonymity of the participants were respected. Population data: 62% female/38% male. Average age: 78.8. Prevalence: SM=57% (Male: 56% and Women: 59%); obesity=69%, hypertriglyceridemia=57%, hypercholesterolemia=49%, HBP=69%, hyperglycemia=54%. Mortality: 11.27% in the period. Increased risk of mortality for people with MS (Masc=1.26; Fem=1.45; OR:1.13). Women with MS have shorter survival (age of death MS: 77.72 vs. Non-MS: 83.88 years). Qualitative and quantitative differences were found in the proportional causes of mortality between the group with MS and those without. MS showed a high prevalence in older adults, equally for all components of its diagnosis. MS increased the risk of mortality and decreased survival, more markedly in women. The diagnosis of MS is important, mainly in vulnerable populations, to improve its prevention and treatment.
publisher Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología
publishDate 2023
url https://revistas.unc.edu.ar/index.php/med/article/view/42714
work_keys_str_mv AT diazgerevinigt metabolicsyndromeinolderadultsapoblationalstudy
AT priottos metabolicsyndromeinolderadultsapoblationalstudy
AT barottonn metabolicsyndromeinolderadultsapoblationalstudy
AT astorquizap metabolicsyndromeinolderadultsapoblationalstudy
AT barbozamc metabolicsyndromeinolderadultsapoblationalstudy
AT lopezpm metabolicsyndromeinolderadultsapoblationalstudy
AT fariass metabolicsyndromeinolderadultsapoblationalstudy
AT repossig metabolicsyndromeinolderadultsapoblationalstudy
AT diazgerevinigt sindromemetabolicoenadultosmayoresunestudiopoblacional
AT priottos sindromemetabolicoenadultosmayoresunestudiopoblacional
AT barottonn sindromemetabolicoenadultosmayoresunestudiopoblacional
AT astorquizap sindromemetabolicoenadultosmayoresunestudiopoblacional
AT barbozamc sindromemetabolicoenadultosmayoresunestudiopoblacional
AT lopezpm sindromemetabolicoenadultosmayoresunestudiopoblacional
AT fariass sindromemetabolicoenadultosmayoresunestudiopoblacional
AT repossig sindromemetabolicoenadultosmayoresunestudiopoblacional
first_indexed 2024-09-03T21:04:52Z
last_indexed 2024-09-03T21:04:52Z
_version_ 1809210400968802304
spelling I10-R327-article-427142023-10-19T21:19:42Z Metabolic syndrome in older adults: a poblational study Síndrome metabólico en adultos mayores: un estudio poblacional Díaz-Gerevini, GT Priotto, S Barotto, NN Astorquiza, P Barboza, MC López, PM Farías, S Repossi, G Metabolic Syndrome older adults Epidemiology Síndrome metabólico Adultos Mayores epidemiologia Metabolic syndrome (MS) is a set of metabolic alterations considered a risk factor for developing cardiovascular disease and diabetes. In recent years, due to harmful changes in lifestyle, the increase in the prevalence of SM worldwide is alarming. In Argentina, epidemiological studies on SM report a prevalence of 25%. One of the groups at highest risk for this syndrome are older adults. Objectives: Determine the prevalence of MS and its diagnostic components. To analyze whether MS is associated with an increase in mortality. A retrospective observational study was carried out (period 2018-2022) of all medical records (n=1020) of older adults (≥65 years), patients at the San Ricardo Pampuri Medical Center, Villa Carlos Paz, Córdoba. Diagnostic criteria for MS: present at least 3 of these 5 components: 1-BMI≥30; 2-Triglycerides ≥ 150 mg/dL; 3-HDL cholesterol ≤40 mg/dL in men or ≤50 mg/dL in women and/or total cholesterol ≥ 200 mg/dL; 4-Elevated blood pressure ≥140/90 mmHg; 5- Fasting glucose ≥100 mg/dL. These variables were analyzed and the prevalence of MS was determined. Mortality and its causes were studied and the risk for patients with MS was calculated. Statistical analysis was performed with Infostat (p≤0.05), ANOVA (Tukey post hoc) tests were used for continuous variables and Chi square for discrete variables. In this work, the rules of confidentiality and anonymity of the participants were respected. Population data: 62% female/38% male. Average age: 78.8. Prevalence: SM=57% (Male: 56% and Women: 59%); obesity=69%, hypertriglyceridemia=57%, hypercholesterolemia=49%, HBP=69%, hyperglycemia=54%. Mortality: 11.27% in the period. Increased risk of mortality for people with MS (Masc=1.26; Fem=1.45; OR:1.13). Women with MS have shorter survival (age of death MS: 77.72 vs. Non-MS: 83.88 years). Qualitative and quantitative differences were found in the proportional causes of mortality between the group with MS and those without. MS showed a high prevalence in older adults, equally for all components of its diagnosis. MS increased the risk of mortality and decreased survival, more markedly in women. The diagnosis of MS is important, mainly in vulnerable populations, to improve its prevention and treatment. El síndrome metabólico (SM) es un conjunto de alteraciones metabólicas consideradas como factor de riesgo para desarrollar enfermedad cardiovascular y diabetes. En los últimos años, debido a cambios perjudiciales en los hábitos de vida el incremento en la prevalencia de SM a nivel mundial es alarmante. En Argentina los estudios epidemiológicos sobre SM, reportan una prevalencia del 25%. Uno de los grupos de mayor riesgo para este síndrome son los adultos mayores. Objetivos: Determinar la prevalencia del SM y sus componentes diagnósticos. Analizar si el SM se asocia con un aumento de la mortalidad. Se realizó un estudio observacional retrospectivo (período 2018-2022) de todas las historias clínicas (n=1020) de adultos mayores (≥65 años), pacientes del Centro Médico San Ricardo Pampuri, Villa Carlos Paz, Córdoba. Criterio diagnóstico de SM: presentar al menos 3 de estos 5 componentes: 1-IMC≥30; 2-Triglicéridos≥ 150 mg/dL; 3-Colesterol HDL≤40 mg/dL en hombres o ≤50 mg/dL en mujeres y/o colesterol total≥ 200 mg/dL; 4-Elevación de la presión arterial ≥140/90 mmHg; 5- Glucosa de ayunas ≥100 mg/dL.  Se analizaron estas variables y se determinó la prevalencia del SM. Se estudió la mortalidad, sus causas y se calculó el riesgo para pacientes con SM. El análisis estadístico se realizó con Infostat (p≤0,05), se usaron test ANOVA (post hoc Tukey) para variables continuas y Chi cuadrado para discretas. En este trabajo se respetaron las normas de confidencialidad y anonimato de los participantes. Datos poblacionales: 62% femenino/38%masculino. Edad promedio:78,8. Prevalencias: SM=57% (Masc: 56% y Fem: 59%); obesidad=69%, hipertrigliceridemia=57%, hipercolesterolemia=49%, HTA=69%, hiperglucemia=54%. Mortalidad: 11,27% en el período. Riesgo aumentado de mortalidad para personas con SM (Masc=1,26; Fem=1,45; OR:1,13). Mujeres con SM tienen menor sobrevida (Edad fallecimiento SM: 77,72 vs No SM: 83,88 años). Se encontraron diferencias cualitativas y cuantitativas en las causas de mortalidad proporcionales entre el grupo con SM y el que no. El SM mostró una alta prevalencia en adultos mayores, igualmente para todos los componentes de su diagnóstico. El SM aumentó el riesgo de mortalidad y disminuyó la sobrevida, más marcadamente en mujeres.  El diagnóstico de SM es importante, principalmente en poblaciones vulnerables, para mejorar su prevención y tratamiento. Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología 2023-10-19 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion application/pdf https://revistas.unc.edu.ar/index.php/med/article/view/42714 Revista de la Facultad de Ciencias Médicas de Córdoba.; Vol. 80 (2023): Suplemento JIC XXIV Revista de la Facultad de Ciencias Médicas de Córdoba; Vol. 80 (2023): Suplemento JIC XXIV Revista da Faculdade de Ciências Médicas de Córdoba; v. 80 (2023): Suplemento JIC XXIV 1853-0605 0014-6722 spa https://revistas.unc.edu.ar/index.php/med/article/view/42714/42880 Derechos de autor 2023 Universidad Nacional de Córdoba http://creativecommons.org/licenses/by-nc/4.0

Ejemplares similares